Jacob Antony Chakiath,
Ravi Kumar Chittoria,
- Professor, Department of Plastic Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Yanam, Pondicherry, India
- Senior Resident, Department of Plastic Surgery, Jawaharlal, Institute of Postgraduate Medical Education and Research, Yanam, Pondicherry, India
Abstract
Telogen effluvium, a condition of non-inflammatory, no-scarring, diffuse hair loss after weight loss surgery. A through history taking and videodermatoscopy is an effective tool for evaluation of a patient with weight loss surgery-induced teleogen effluvium (We Loss SITE). Cyclical nutritional therapy, low level laser therapy, autologous platelet rich plasma are effective treatments for telogen effluvium. This case report shares our experience in the management of a patient with weight loss surgery-induced telogen effluvium. An OPD visit was made by a 23-year-old male patient from Calicut, Kerala, who works as a driver and has had hair loss for two years following bariatric surgery. Since childhood, the patient has been obese. When she became pregnant, his mother had uncontrolled diabetes. At nine months old, she had a caesarean section because of macrosomia. When the patient was delivered, their weight was 6 kg. With age, he began to put on weight gradually. It might be challenging to differentiate between female pattern hair loss and telogen effluvium, a non-inflammatory, widespread hair loss disorder. The entire scalp usually experiences hair loss, albeit on occasion the temporal regions show the most signs of it. The hair-pull test is positive, with increased shedding of telogen hairs when telogen effluvium is active. In our patient with weight loss surgery induced telogen effluvium, videodermatoscopy was helpful for diagnosis. Autologous platelet-rich plasma therapy, low-intensity laser therapy, and cyclical nutritional therapy all contributed to the restoration of better hair.
Keywords: Weight loss surgery, bariatric, videodermatoscopy, low-level laser, cyclical nutritional therapy, platelet rich plasma, telogen effluvium
[This article belongs to Research & Reviews : A Journal of Medical Science and Technology (rrjomst)]
Jacob Antony Chakiath, Ravi Kumar Chittoria. Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) Management – Our Experiences. Research & Reviews : A Journal of Medical Science and Technology. 2024; 13(03):-.
Jacob Antony Chakiath, Ravi Kumar Chittoria. Weight Loss Surgery Induced Telogen Effluvium (We Loss SITE) Management – Our Experiences. Research & Reviews : A Journal of Medical Science and Technology. 2024; 13(03):-. Available from: https://journals.stmjournals.com/rrjomst/article=2024/view=182673
References
- Thiedke CC. Alopecia in women. Am Fam Physician. 2003;67(5):1007–1014.
- Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009;80(4):356–362.
- Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–WE03. doi:7860/JCDR/2015/15219.6492.
- Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019;12:583–590. doi:10.2147/CCID.S200471.
- Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006;55(5):799–806. doi:10.1016/j.jaad.2006.04.058.
- Bernstein RM, Rassman WR. Densitometry and video-microscopy. Hair Transplant Forum Int. 2007;17(2):41–51. doi:10.33589/17.2.0041.
- Irwig MS. Persistent sexual side effects of finasteride: could they be permanent?. J Sex Med. 2012;9(11):2927–2932. doi:10.1111/j.1743-6109.2012.02846.x.
- Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872–884. doi:10.1111/j.1743-6109.2010.02157.x.
- Rajput Rajendrasingh RR. The concept of cyclical nutritional therapy for hair growth which can be applied for wellness. J Nutr Food Sci. 2017;7(4):615. doi:10.4172/2155-9600.1000615.
- Roughead ZK, Zito CA, Hunt JR. Inhibitory effects of dietary calcium on the initial uptake and subsequent retention of heme and nonheme iron in humans: comparisons using an intestinal lavage method. Am J Clin Nutr. 2005;82(3):589–597. doi:10.1093/ajcn.82.3.589.
- Brown Jr EB, Dubach R, Moore CV. Studies in iron transportation and metabolism. 11. Critical analysis of mucosal block by large doses of inorganic iron in human subjects. J Lab Clin Med. 1958;52:335–355.
- Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr. 1996;16(1):33–50. doi:10.1146/annurev.nu.16.070196.000341.
- Halliwell B. The antioxidant paradox. Lancet. 2000;355(9210):1179–1180. doi:10.1016/S0140-6736(00)02075-4.
- Wang L, Li Q, Duan XL, Chang YZ. Effects of extracellular iron concentration on calcium absorption and relationship between Ca2+ and cell apoptosis in Caco-2 cells. World J Gastroenterol. 2005;11(19):2916–2921. doi:3748/wjg.v11.i19.291.
- Meydani M. Antioxidants in the prevention of chronic diseases. Nutrition in clinical care: an official publication of Tufts University. 2002;5(2):47–49. doi:1046/j.1523-5408.2002.00002.x.
- Rutkowski M, Grzegorczyk K. Adverse effects of antioxidative vitamins. Int J Occup Med Environ Health. 2012;25(2):105–121. doi:10.2478/S13382-012-0022-x.
- Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014;40(9):1010–1019. doi:10.1097/01.DSS.0000452629.76339.2b.
- Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–127. doi:10.1007/s40257-013-0060-6.
- Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device–controlled multicenter trial. Dermatol Surg. 2013;39(8):1177–1183. doi:10.1111/dsu.12200.
Volume | 13 |
Issue | 03 |
Received | 13/03/2024 |
Accepted | 08/05/2024 |
Published | 13/11/2024 |